Cargando…
Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
Non-replicating rotavirus vaccines are an alternative strategy to improve the efficacy and safety of rotavirus vaccines. The spike protein VP4, which could be enzymatically cleaved into VP8∗ and VP5∗, is an ideal target for the development of recombinant rotavirus vaccine. In our previous studies, w...
Autores principales: | Luo, Guoxing, Zeng, Yuanjun, Yang, Han, Li, Yijian, Yang, Lianwei, Li, Cao, Song, Feibo, Zhang, Shiyin, Li, Tingdong, Ge, Shengxiang, Zhang, Jun, Xia, Ningshao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519587/ https://www.ncbi.nlm.nih.gov/pubmed/36185383 http://dx.doi.org/10.1016/j.isci.2022.105099 |
Ejemplares similares
-
Establishment of Sandwich ELISA for Quality Control in Rotavirus Vaccine Production
por: Li, Cao, et al.
Publicado: (2022) -
Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana
por: Malm, Maria, et al.
Publicado: (2019) -
Classification of group A rotavirus VP7 and VP4 genotypes using random forest
por: Tran, Hoc, et al.
Publicado: (2023) -
Codon usage of host-specific P genotypes (VP4) in group A rotavirus
por: Wu, Han, et al.
Publicado: (2022) -
Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine
por: Maina, Meshach Maunta, et al.
Publicado: (2022)